Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

被引：4
|
作者：
Kim, Young-Hak [1 ]
机构：
[1] Kyoto Univ, Kyoto, Japan
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2019年 / 380卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：989 / 990
页数：2
相关论文
共 50 条
  • [11] Quality of life with durvalumab in stage III non-small-cell lung cancer
    Anota, Amelie
    Westeel, Virginie
    LANCET ONCOLOGY, 2019, 20 (12): : 1619 - 1620
  • [12] Development of Bronchopleural Fistula After Durvalumab Consolidation for Stage III Non-Small-Cell Lung Cancer
    Darwin, Alicia
    Rose, Trevor
    Tandon, Amit
    Tanvetyanon, Tawee
    CLINICAL LUNG CANCER, 2021, 22 (01) : E18 - E24
  • [13] Concurrent chemoradiotherapy for inoperable stage III non-small-cell lung cancer
    Robert MacRae
    Hak Choy
    Current Oncology Reports, 2003, 5 (4) : 313 - 317
  • [14] The role of chemoradiotherapy in the treatment of stage III non-small-cell lung cancer
    Eberhardt, W
    Gauler, T
    Hepp, R
    Korfee, S
    Pöttgen, C
    Stamatis, G
    Stuschke, M
    ANNALS OF ONCOLOGY, 2004, 15 : 71 - 80
  • [15] Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
    Spigel, David R.
    Faivre-Finn, Corinne
    Gray, Jhanelle E.
    Vicente, David
    Planchard, David
    Paz-Ares, Luis
    Vansteenkiste, Johan F.
    Garassino, Marina C.
    Hui, Rina
    Quantin, Xavier
    Rimner, Andreas
    Wu, Yi-Long
    Ozguroglu, Mustafa
    Lee, Ki H.
    Kato, Terufumi
    de Wit, Maike
    Kurata, Takayasu
    Reck, Martin
    Cho, Byoung C.
    Senan, Suresh
    Naidoo, Jarushka
    Mann, Helen
    Newton, Michael
    Thiyagarajah, Piruntha
    Antonia, Scott J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (12) : 1301 - +
  • [16] Consolidation Chemotherapy After Concurrent Chemoradiotherapy in Patients With Stage III Non-Small-Cell Lung Cancer
    Kim, Young Hak
    Mishima, Michiaki
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07) : 767 - +
  • [17] Real-World Analysis of Durvalumab after Chemoradiation in Stage III Non-Small-Cell Lung Cancer
    Preti, Beatrice T. B.
    Sanatani, Michael S.
    Breadner, Daniel
    Lakkunarajah, Suganija
    Scott, Carolyn
    Esmonde-White, Caroline
    Mcarthur, Eric
    Rodrigues, George
    Chaudhary, Mitali
    Mutsaers, Adam
    Sachdeva, Robin
    Vincent, Mark D.
    CURRENT ONCOLOGY, 2023, 30 (08) : 7713 - 7721
  • [18] Rationale for concurrent chemoradiotherapy for patients with stage III non-small-cell lung cancer
    John Conibear
    British Journal of Cancer, 2020, 123 : 10 - 17
  • [19] Rationale for concurrent chemoradiotherapy for patients with stage III non-small-cell lung cancer
    Conibear, John
    BRITISH JOURNAL OF CANCER, 2020, 123 (SUPPL 1) : 10 - 17
  • [20] Outcomes of chemoradiotherapy for stage III non-small-cell lung cancer in Brazil.
    Coelho, Juliano Ce
    Bedin, Sabrina Richter
    Silva, Bruna C.
    Liedke, Pedro Emanuel Rubini
    Geib, Guilherme
    Pirolli, Rafaela
    Branco, Mariane
    Muller, Carolina
    de Bastiani, Marco Antonio
    Klamt, Fabio
    Azevedo, Sergio Jobim
    Schwartsmann, Gilberto
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345